Study objective-To investigate asthma mortality during 1920-94 in Australia in order to assess the relative role of period and birth cohort effects. Design-Asthma mortality (both sexes) was age standardised and examined for changes over time. The data were also examined for age, period, and cohort
(APC) effects using Poisson regression modelling. Setting-National Australian mortality data. Participants-Population (both sexes) aged 15-34 years, 1920-94. Main results-Age adjusted period rates indicate an increase in asthma mortality during the 1950s, and increases and subsequent falls (epidemics) during the mid 1960s and late 1980s. APC modelling suggested an increasing cohort effect (adjusted for both age and period) from the birth cohort 1950-54 onwards. Period effects (adjusted for age and cohort) are characterised by an increase in the 1950s (possibly due to changes in diagnostic labelling), minimal or no increases in the mid 1960s and late 1980s (where period peaks had been noted when data were adjusted for age only), and declines in mortality risk subsequent to the periods where age-period analysis had noted increases. Thus, in Australia, some of the mid 1960s epidemic in asthma deaths, and all of the late 1980s mortality increase, seem to be attributable to cohort effects. Conclusions-The increase in asthma mortality cohort effect is consistent with empirical evidence of recent increases in prevalence (and presumably incidence) of asthma in Australia, and suggests the need for more research into the underlying environmental aetiology of Recent research suggests that the prevalence of asthma is increasing in the Australian population,'01' which implies increase in incidence, since mortality is very low, even during peak periods.
We examine trends in asthma mortality (ages 5-34 years) for 1920-94, and explore the possible existence ofunderlying birth cohort effects which would not necessarily be obvious from plots of age adjusted data in relation to period. Cohort 
Results
Age standardised asthma mortality (fig 1) remained low (<0.5/100 000) from 1920 to 1953, after which there was a sustained increase to levels around 1 per 100 000 from the mid 1950s to the mid 1960s. The mid 1960s epidemic of asthma deaths then ensued, which peaked at KEY POINTS * Australia experienced two epidemics of asthma deaths between 1920 and 1994, one in the mid 1960s and the other in the late 1980s. * Age-period-cohort modelling showed that some of the increase in asthma deaths in the mid 1960s and all of the late 1980s rise seemed to be a result of birth cohort effects. * The increasing risk of asthma death with more recent birth cohorts is consistent with evidence of an increasing prevalence (and presumably incidence) of asthma in Australia.
If increasing birth cohort trends continue, mortality will only be controlled by ever improving treatment, which may be difficult to sustain. (fig 2) . A progressively increasing cohort effect was obvious from the birth cohort of 1950-54 onwards (fig 4) . The plot of the period effect (adjusted for age and cohort) reveals an increase during the 1950s, a slight peak in the mid-1960s, a decline during the 1970s (except for a single year peak), a flat trace during the 1980s, and a decline during the early 1990s (fig 3) .
Discussion
Analysis of asthma mortality at a population level is complicated by the relatively small number of annual deaths, and consequently stochastic fluctuation, and by diagnostic difficulties when data are derived from death certificates. Misclassification bias can be limited by restricting analysis of asthma mortality to ages 5-34 years since this excludes confusion with other respiratory conditions of early childhood, and avoids the problem of differentiating asthma from the chronic airflow limitation disease complex in adults.2" Misclassification of year of death may also occur because of delays in notification or registration and coding. Such phenomena may account for the single year peak observed in 1974.
Changes in mortality rates over time may also occur as a result of misclassification bias through shifts in diagnostic labelling and coding criteria. 25 The change from ICD-5 to ICD-6 occurred in 1950, but the sustained rise in asthma mortality did not occur until 1953. Moreover, most of the 1950s increase was over before the introduction of ICD-7 in 1957.
Data for Australian asthma deaths for all ages indicates a sharp rise in 1950 with the change in ICD-5 to ICD-6 as cases of "Asthmatic Bronchitis" were recoded from bronchitis to asthma. However, there is no evidence to suggest this affected the 5-34 year mortality data. Thus, the rise in asthma deaths during the 1950s is unlikely to be a coding artefact, but could have been a consequence of changes in diagnostic labelling by medical doctors. The APC modelling implies that the 1950s increase is entirely a period effect which is consistent with this explanation. The increase in death rates could also have been treatment related, although this would be difficult to substantiate.
APC modelling presents difficulties because any one variable may be derived from the other two, producing the problem of non-identifiability. Although there is no ultimate solution to this problem, a unique solution in the regression analysis can be found by imposing certain restrictions. We used single period years and five year age and cohort brackets, and aggregated the youngest and oldest cohorts in order to permit Poisson regression analysis of the data. This may have had an impact on apparent patterns. Use ofdifferent width cohort and period brackets was also used by Burney 
